Skip to main content

Table 1 Study population

From: Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis

Status

Group ID

Number

Average age

Leishmania species

Cured from CL

CCLm

30

43.34 ± 13.07

L. major

Healthy high responder (L. major)

HHRLm

18

39.17 ± 10.40

L. major

Healthy high responder (L. infantum)

HHRLi

26

35.75 ± 9.55

L. infantum

Healthy low responders

HLR

17

30.76 ± 5.73

–

  1. Abbreviations: CCLm Cured from cutaneous leishmaniasis due to L. major, HHRLm Healthy High Responders (L. major), HHRLi Healthy High Responders (L. infantum), HLR, naïves control
  2. The recruitment and peripheral blood sampling of different groups including cured from CL due to L. major (CCLm) and individuals with a probable asymptomatic L. major (HHRLm) or L. infantum infection (HHRLi), were performed in endemic foci for CL due to L. major and VL due to L. infantum. Healthy individuals with no history of leishmaniasis, used as naïve controls (HLR) were recruited from a low-endemic area